• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Cognitive behavioral therapy effective for depression but not self-care in heart failure

byShayna BejaimalandJames Jiang
September 29, 2015
in Cardiology, Psychiatry
Reading Time: 2 mins read
Image-guided percutaneous drainage of pericardial effusions is safe and effective
Share on FacebookShare on Twitter

1. In this randomized controlled trial, heart failure patients randomized to cognitive behavioral therapy (CBT) had decreased depression as compared to usual care, but there was no significant impact on self-care.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Mental illnesses, such as major depressive disorder, may impact the ability of a patient with chronic disease to provide self-care. In particular, depression in heart failure patients is associated with poorer quality of life and increased risk of hospitalization and mortality. Given that self-care (i.e., following low sodium diet, exercising, taking medications as prescribed) is important in heart failure, it is vital to understand how we can improve self-care by controlling concomitant depression. This randomized controlled trial aimed to determine the efficacy of a CBT intervention for depression and self-care.

Integrative CBT was not significantly associated with improved self-care or physical functioning measures. However, CBT was associated with a significant decrease in depression. There were fewer hospitalizations and increased heart failure-related quality of life and social functioning scores in the CBT arm. However, hospitalization was an exploratory outcome, and groups did not differ on composite endpoint of death or hospitalization. The strengths of this study include studying cognitive behavioural therapies as opposed to medications, which were historically studied. Limitations of this study include having low enrollment. Although this did not underpower the primary outcomes, secondary and exploratory outcomes including hospitalizations should be interpreted with caution.

Click to read the study, published today in JAMA Internal Medicine

Relevant Reading: Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure

RELATED REPORTS

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

In-Depth [randomized controlled trial]: This randomized, single-blinded trial was conducted in Missouri, between January 2010 and June 2013. It included 158 patients with New York Heart Association (NYHA) class I-III heart failure and comorbid major depression. These patients were randomized to either cognitive behaviour therapy delivered by an experienced therapist plus usual care, or usual care alone. Usual care consisted of a structured heart failure education program provided by a cardiac nurse. The outcomes of interest included severity of depression at 6 months assessed by the Beck Depression Inventory; self-care as defined by the Self-Care of Heart Failure index, and as exploratory outcomes, hospitalizations and death.

A total of 158 patients were randomized with 79 to usual care and 79 to CBT with usual care. Antidepressant use at baseline was equal between groups. Depression scores at 6 months were lower in the CBT group as compared to the usual care arm (difference -4.43; 95%CI -7.68 to -1.18; p = 0.008). The groups did not differ on the self-care maintenance or confidence subscales. There was no significant difference between absolute numbers of hospitalizations between the usual care and CBT groups (35 vs. 32, p = 0.63). However, after controlling for antidepressant use, use of Poisson model and counting multiple readmissions, patients in the CBT arm had a lower rate of hospitalizations compared to usual care (incidence rate ratio 0.47; 95%CI 0.30-0.76; p = 0.002).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: congestive heart failuredepression
Previous Post

Shared decision-making tool for antidepressants improves patient and physician satisfaction

Next Post

Bariatric surgery beneficial in type-2 diabetes, similar in cost to conventional treatment

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Parents often unaware of adolescents’ suicidal thoughts
Psychiatry

Psychotherapy identified as most effective treatment for grief

February 2, 2026
Next Post
Addressing non-obesity related barriers may improve bariatric surgery effectiveness

Bariatric surgery beneficial in type-2 diabetes, similar in cost to conventional treatment

Lung cancer screening may lower motivation for smoking cessation

Novel links identified between genetics, lung function and smoking behavior

Brodalumab effective in treating active psoriatic arthritis

Anti-interleukin-17A therapy shows promise in psoriatic arthritis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.